Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA clears IND application for EIDD-2801 for COVID-19

April 7, 2020

FDA accepts IND for phase I testing of INO-4800 for COVID-19

April 7, 2020

Pfizer discloses new CCR6 antagonists

April 7, 2020

Hanmi Science presents new EGFR mutant inhibitors

April 7, 2020

Bristol-Myers Squibb synthesizes new LPA1 receptor antagonists

April 7, 2020

Chinese researchers patent compounds for cancer

April 7, 2020

Ono Pharmaceutical divulges PTGDR2 antagonists

April 7, 2020

Novel alpha-ketoamide inhibitor with activity against main protease of SARS-CoV-2

April 7, 2020

IRF-1 as a novel therapeutic target in CKD

April 7, 2020

Mesoblast's IND for remestemcel-L in COVID-19-related ARDS receives clearance

April 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...